drugset / Trial / NCT06629129

Effect of Latanoprost on Optic Nerve Perfusion

NCT06629129

Phase 1 Completed 46 enrolled Zagazig University
NaSingle-groupOpen-labelTreatment

Summary

46 eyes of 23 patients have been treated with topical Latanoprost 0.005 %. visual field was performed on all eyes. NFLT was measured using OCT. Radial peripapillary capillary (RPC) vascular density was measured using OCTA . mean ocular perfusion pressure (MOPP), and RPC vascular density were measured before and after treatment BY 2-3 MONTHS

Timeline

Start
2024-06-24
Primary completion
2024-08-30
Completion
2024-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Latanoprost Small molecule 0.005 % Topical

Indications

No indication recorded.